Trial Profile
A Phase 1, Double-Blind, Randomized, Placebo-Controlled, Sequential-Group Study to Assess the Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of AER-271 in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs AER-271 (Primary)
- Indications Brain oedema
- Focus Adverse reactions; First in man
- Sponsors Aeromics
- 07 Jan 2020 Status changed from recruiting to completed, according to an Aeromics media release.
- 07 Jan 2020 According to an Aeromics media release, Dr. Schindler Have been closely associated with this trial.
- 26 Jul 2018 New trial record